Research Calls
- Upgrades:
- Alignment Healthcare (ALHC) upgraded to Outperform from Mkt Perform at Raymond James; tgt $9
- Allbirds (BIRD) upgraded to Outperform from Market Perform at Telsey Advisory Group; tgt $1.50
- AvalonBay (AVB) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $193
- Banco Bilbao Vizcaya Argentaria (BBVA) upgraded to Buy from Hold at HSBC Securities
- Biogen (BIIB) upgraded to Buy from Neutral at Guggenheim; tgt raised to $350
- Carter Bank & Trust (CARE) upgraded to Outperform from Mkt Perform at Raymond James; tgt $17
- Comcast (CMCSA) upgraded to Buy from Neutral at BofA Securities; tgt raised to $49
- General Motors (GM) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $38
- IAMGOLD (IAG) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $3.25
- Logitech Int'l SA (LOGI) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $56
- Manitowoc (MTW) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $17
- Otis Worldwide (OTIS) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $88
- Scotts Miracle-Gro (SMG) upgraded to Buy from Hold at Stifel; tgt raised to $80
- Teradata (TDC) upgraded to Buy from Neutral at Guggenheim; tgt $62
- Zillow (ZG) upgraded to Mkt Perform from Underperform at Bernstein; tgt raised to $45
- Downgrades:
- ArcBest (ARCB) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $91
- Banco Santander (SAN) downgraded to Hold from Buy at HSBC Securities
- Doximity (DCOS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $37
- Exxon Mobil (XOM) downgraded to Neutral from Buy at Goldman; tgt $125
- IVERIC bio (ISEE) downgraded to Neutral from Buy at Guggenheim
- Principal Fincl (PFG) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $78
- South Atlantic Bancshares (SABK) downgraded to Neutral from Buy at Janney; tgt lowered to $14
- Valley National (VLY) downgraded to Mkt Perform from Strong Buy at Raymond James
- Others:
- Danaher (DHR) initiated with an Outperform at SVB Securities; tgt $300
- Edgewise Therapeutics (EWTX) initiated with a Buy at Truist
- Endeavor Group (EDR) initiated with a Buy at Guggenheim; tgt $33
- Immunovant Sciences (IMVT) initiated with a Buy at BofA Securities; tgt $26
- MoonLake Immunotherapeutics (MLTX) initiated with a Buy at Guggenheim; tgt $51
- TD Synnex (SNX) initiated with a Buy at Goldman; tgt $101
- Treace Medical Concepts (TMCI) initiated with a Buy at Truist; tgt $33